Capricor Therapeutics CAPR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's retained earnings?
- Capricor Therapeutics (CAPR) reported retained earnings of -$338.82M in Q1 2026.
- How has Capricor Therapeutics's retained earnings changed year-over-year?
- Capricor Therapeutics's retained earnings decreased by 51.1% year-over-year, from -$224.23M to -$338.82M.
- What is the long-term trend for Capricor Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Capricor Therapeutics's retained earnings has grown at a 28.2% compound annual growth rate (CAGR), from -$88.04M to -$304.88M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.